baber/WOPTO huggingface dataset:
Patent CY-1111672-T1 (CY)
Title: Παραγωγα αντιγονου σχετιζομενα με ογκους απο την οικογενεια των mage, τα οποια χρησιμοποιουνται για την παρασκευη πρωτεϊνων συντηξης με τ βοηθητικα επιτοπα και συνθεσεων για εμβολιασμο
Inventor: CABEZON SILVA TERESA
IPC: C12N15/70
Filed: 2011-07-08
Abstract: Η παρούσα εφεύρεση αφορά νέες πρωτεΐνες και την παρασκευή τους, από την οικογένεια MAGE. Πιο συγκεκριμένα, μια πρωτεΐνη MAGE, συντηγμένη σε έναν ανοσολογικό εταίρο σύντηξης, όπως η Λιποπρωτεΐνη D. Τέτοια αντιγόνα μπορούν να διατυπωθούν ώστε να παράσχουν εμβόλια για την αντιμετώπιση ενός εύρος όγκων. Επίσης παρουσιάζονται νέες μέθοδοι για τον καθαρισμό των πρωτεϊνών MAGE.
Patent CY-1118203-T1 (CY)
Title: Κατιονika παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων
Inventor: SCHERZ AVIGDOR
IPC: A61K41/00
Filed: 2016-10-27
Abstract: Η εφεύρεση παρέχει κατιονικά τετρακυκλικά και πεντακυκλικά παράγωγα βακτηριοχλωροφύλλης (Bchls) που περιέχουν τουλάχιστον μία θετικώς φορτισμένη ομάδα ή/και τουλάχιστον μια βασική ομάδα, η οποία μετατρέπεται προς θετικώς φορτισμένη ομάδα υπό φυσιολογικές συνθήκες, κατά προτίμηση Bchls που έχουν ομάδες ωνίου προερχόμενες από αλειφατική ή ετεροκυκλική ρίζα που περιέχει Ν όπως αμμώνιο, γουανιδίνιο, ιμιδαζόλιο, πυριδίνιο, και τα παρόμοια τους ή ομάδα φωσφονίου, αρσονίου, οξονίου, σουλφονίου, σεληνονίου, τελλουρονίου, στιβονίου, ή βισμουθονίου ή βασική ομάδα η οποία μετατρέπεται προς τέτοιες ομάδες ωνίου υπό φυσιολογικές συνθήκες, οι εν λόγω δε ομάδες είναι δεσμευμένες προς μία ή περισσότερες από τις θέσεις 173, 133 και 32 του Bchl μορίου μέσω εστέρα ή δεσμού αμιδίου. Τα Bchls είναι χρήσιμα για φωτοδυναμική θεραπεία και διάγνωση.
Patent CY-1120644-T1 (CY)
Title: Μικροκαψουλες παρατεταμενης αποδεσμευσης με βαση πολυ(λακτιδιο-συν-γλυκολιδιο) που περιεχουν ενα πολυπεπτιδιο και ενα σακχαρο
Inventor: FINEMAN MARK
IPC: A61K38/28
Filed: 2018-08-30
Abstract: Αυτή η εφεύρεση αναφέρεται σε συνθέσεις για την παρατεταμένη αποδέσμευση βιολογικώς δραστικών πολυπεπτιδίων και μεθόδους σχηματισμού και χρήσης των εν λόγω συνθέσεων, για την παρατεταμένη αποδέσμευση βιολογικώς δραστικών πολυπεπτιδίων. Οι συνθέσεις παρατεταμένης αποδέσμευσης αυτής της εφεύρεσης αποτελούνται από ένα βιοσυμβατό πολυμερές που έχει διασπαρθεί σε αυτές, ένα βιολογικώς δραστικό πολυπεπτίδιο και ένα σάκχαρο.
Patent CY-1122990-T1 (CY)
Title: Μια μεθολος για τη διαχειριση ενος πακετου ανακατεμενων χαρτιων τραπουλας
Inventor: SHIGETA YASUSHI
IPC: A63F1/06
Filed: 2020-06-10
Abstract: Η παρούσα εφεύρεση έχει επινοηθεί ενόψει ενός αντικειμένου παροχής μίας μεθόδου για τη διαχείριση ενός πακέτου ανακατεμένων χαρτιών τράπουλας για την πρόληψη της ανταλλαγής χαρτιών σε καζίνο με στόχο την εξαπάτηση. Το σύστημα διαχείρισης 7 είναι προγραμματισμένο να υπολογίζει θέσεις και έναν αριθμό όλων των πακέτων 2 των ανακατεμένων χαρτιών τράπουλας σε κάθε μέρος της αυλής 8, στα σημεία των τραπεζιών παιχνιδιού 11, στις θέσεις των φορέων 9 και το χώρο διάθεσης 10 με τη χρήση πληροφοριών που λαμβάνονται από το βήμα φόρτωσης και το βήμα εκφόρτωσης και το σύστημα διαχείρισης 7 υπολογίζει με βάση κάθε κωδικό αναγνώρισης ID 1) θέσεις όλων των πακέτων που καταχωρούνται από το βήμα εγγραφής για εγγραφή σε μια βάση δεδομένων του συστήματος διαχείρισης 7 και κάθε αριθμού πακέτων ανά θέση από τις πληροφορίες που λαμβάνονται τόσο από το βήμα φόρτωσης όσο και το βήμα εκφόρτωσης. Και στη συνέχεια το σύστημα διαχείρισης 7 προγραμματίζεται για να αναγνωρίζει κατά πόσο υπάρχει ή όχι χαμένο πακέτο συγκρίνοντας τις πληροφορίες όλων των νημάτων αναγνώρισης ID που είναι καταχωρημένα στο βήμα καταχώρισης με τα νήματα αναγνώρισης ID σε κάθε θέση όλων των πακέτων που λαμβάνονται στο βήμα υπολογισμού τόσο από το βήμα φόρτωσης όσο και το βήμα εκφόρτωσης και με αναφορά σχετικά με το χαμένο πακέτο σε ένα τμήμα διαχείρισης ή σε έναν κύριο οργανισμό διαχείρισης.
Patent CY-1123149-T1 (CY)
Title: Μεθοδος για την παρασκευη φαρμακευτικης συνθεσης που περιλαμβανει παραγωγο κινολινης ή αλας αυτου
Inventor: LU YUN
IPC: A61K31/4709
Filed: 2020-07-27
Abstract: Η παρούσα εφεύρεση παρέχει μία μέθοδο για την παρασκευή μιας φαρμακευτικής σύνθεσης που περιλαμβάνει ένα παράγωγο κινολίνης ή ένα άλας αυτού. Συγκεκριμένα, η εφεύρεσης παρέχει μία μέθοδο για την παρασκευή μιας φαρμακευτικής σύνθεσης που περιλαμβάνει ένα (R,Ε)-Ν-(4-(3-χλωρο-4-(πυριδιν-2-υλομεθοξυ)φαινυλαμινο)-3-κυανο-7-αιθοξυκινολιν-6-υλ)-3-(1-μεθυλοπυρρολιδιν-2-υλ)-προπεναμίδιο, ή ενός φαρμακολογικά αποδεκτό άλας αυτού. Η μέθοδος περιλαμβάνει τη χρήση ενός παράγοντα διαβροχής που περιλαμβάνει τουλάχιστον έναν οργανικό διαλύτη για μία υγρή κοκκοποίηση σε μία διεργασία παρασκευής της φαρμακευτικής σύνθεσης. Η φαρμακευτική σύνθεση που παρασκευάζεται με τη χρήση της μεθόδου έχει μία ομοιόμορφη κατανομή μεγέθους κόκκων κατά τη διάρκεια της διεργασίας παρασκευής και μία ιδιότητα ταχείας και ομοιόμορφης διαλυτοποίησης.
Patent HR-P20110891-T1 (HR)
Title: Therapeutic agents useful for treating pain
Inventor: KYLE DONALD
IPC: A61P13/02
Filed: 2011-11-29
Abstract: Compounds of formulae (I) and (II) where X is S or O and Ar 2 , R 1 , R 2 , R 3 , R 8 , n, m, and t are disclosed herein, or a pharmaceutically acceptable salt thereof (a "3-substituted Pyridyl Compound"), compositions comprising an effective amount of a 3-substituted Pyridyl Compound, and methods for treating or preventing pain, urinary incontinence, an ulcer, inflammatory-bowel disease, irritable-bowel syndrome, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a 3-substituted Pyridyl Compound are disclosed herein.
Patent HR-P20120074-T1 (HR)
Title: Energy carrier coupling and coupling with an energy carrier coupling
Inventor: DIETMAR MARTIN
IPC: E02F3/36
Filed: 2012-01-23
Abstract: The coupling has a guiding unit and a centering unit co-operating with each other. The guiding- and centering units are provided at components and/or connecting plates (16) for aligning the connecting plates relative to one another. A protection element (51) i.e. protection cap, is arranged at an energy coupling part in a position changeable manner. An energy coupling element (18) is covered when the energy coupling part in a closed position and not coupled with another energy coupling part. The element is provided in an open position when the former part is in an open position. An independent claim is also included for a coupler for attaching a working implement to a work machine.
Patent SI-1218205-T1 (SI)
Title: Transfer label
Inventor: BLOM PATRICK JOHANNES
IPC: B44C1/17
Filed: 2000-08-24
Abstract: The invention is directed to a transfer label material for image transfer, comprising a backing carrier material and a transfer layer, said transfer layer at least comprising an image layer, an adhesive layer and a pigmented layer between the adhesive layer and the image layer, said pigmented layer comprising a binder material, at least one white pigment and at least 0.1 wt. %, calculated on the basis of the pigmented layer, of aluminum powder (dry weight).
Patent SI-1352837-T1 (SI)
Title: Process for manufacturing a sterilized squeezable package for a pharmaceutical product
Inventor: KIS GYOERGY LAJOS
IPC: B65B55/00
Filed: 2000-05-26
Abstract: A process for manufacturing a sterilized squeezable package of a pharmaceutical product, said package being a polypropylene bottle assembly which process comprises the steps: placing the package after having been filled with said pharmaceutical composition and closed, into an autoclaving chamber, adjusting the temperature and the pressure in said chamber as a function of time in accordance to the prerequisites of the material of said package, wherein a counter pressure is generated in said chamber and wherein this is regulated electronically via computer control, and wherein said counter pressure avoids a deformation of said package so that said package shows after an autoclaving processing of at least 121  DEG C and for at least 20 minutes no deformation such as shrinkage or blowing-up and retains a sufficient high squeezability in order to dispense said product.
Patent SI-1448891-T1 (SI)
Title: Wind energy park around a building, to be protected
Inventor: WOBBEN ALOYS
IPC: E04H9/00
Filed: 2002-10-31
Abstract: A wind energy park comprises a large number of wind turbines (WEA) placed around a building (AKW) which it is desired to protect, e.g. from terrorist attack by air. The turbines are placed as close as possible to each other and to the building.
Patent SI-1776874-T1 (SI)
Title: Method for producing a protein forage supplement from a keratin-containing stock
Inventor: BRENNER VALERY VLADIMIROVICH
IPC: A23K1/00
Filed: 2004-12-03
Abstract: The invention relates to forage production and can be used by factories for processing animal product refused screenings. The inventive method for producing a food supplement from a keratin-containing raw material consists in heating, grinding, sterilising and drying an initial raw material whose moisture ranges from 35 to 95 %, in subsequently compacting and heating in a mixer-grinder channel with a continuous feeding at a pressure of 0.4-10.0 mPa and the raw material temperature ranging from 60 to 120 °C followed by a hydrothermal processing thereof with a temperature of 150-250 °C for 5-300 seconds associated with simultaneous fine grinding and abrasion. Afterwards, the thus processed raw material is transferred to an atmospheric pressure area. The inventive method makes it possible to simplify a production process, reduce costs and improve the quality of the protein supplement.
Patent SI-1656450-T1 (SI)
Title: Cephalosporin c acylase mutant and method for preparing 7-aca using same
Inventor: SHIN YONG CHUL
IPC: C12N9/00
Filed: 2004-08-10
Abstract: A CPC acylase mutant of the present invention has an improved reactivity and specific activity to CPC, which can be efficiently employed for directly preparing 7-ACA from CPC by a one-step enzymatic method.
Patent SI-1765404-T1 (SI)
Title: Combinations comprising antimuscarinic agents and beta-adrenergic agonists
Inventor: GRAS ESCARDO JORDI
IPC: A61K31/00
Filed: 2005-05-31
Abstract: A combination which comprises (a) a PDE4 inhibitor and (b) an antagonist of M3 muscarinic receptors which is (3R)-1-phenethyl-3-(9H-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2]octane, in the form of a salt having an anion X, which is a pharmaceutically acceptable anion of a mono or polyvalent acid.
Patent SI-2094890-T1 (SI)
Title: Method for obtaining high-tenacity aramid yarn
Inventor: BOERSTOEL HANNEKE
IPC: D02G3/00
Filed: 2007-11-19
Abstract: The invention relates to a method for obtaining high-tenacity aramid yarn, wherein the yarn is made of a copolymer obtained from a mixture of monomers comprising DAPBI, an aromatic para-diamine, and an aromatic para-diacid, wherein the yarn is heated in at least two process steps, characterized in that in a first step the yarn is heated at a temperature of 200 to 360° C. at a tension of at least 0.2 cN/dtex, followed by a second step wherein the yarn is heated at a temperature of 370 to 500° C. at a tension of less than 1 cN/dtex. The invention further pertains to a multifilament aramid yarn spun from a sulfuric acid spin dope and having a tenacity of at least 2500 mN/tex.
Patent SI-2323633-T1 (SI)
Title: Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
Inventor: BROWN JONATHAN R
IPC: A61K9/00
Filed: 2009-09-03
Abstract: A pharmaceutical composition contains the compound 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, and hydroxypropyl methyl cellulose (HPMC) having a viscosity of at least about 100 cP, wherein the composition does not contain any enzyme inhibitors.
Patent DE-3751834-T2 (DE)
Inventor: COPPEL ROSS
IPC: C12N15/00
Filed: 1987-12-16
Granted: 1996-11-07
Abstract: Isolated peptides and polypeptides exhibiting the antigenicity of the 70 kD mitochondrial autoantigen of primary biliary cirrhosis are provided. The peptides, polypeptides and antigenic fragments thereof are useful in the diagnosis and treatment of primary biliary cirrhosis.
Patent DE-3852181-T2 (DE)
Inventor: LOCHRIDGE EDWIN
IPC: A47B21/03
Filed: 1988-08-22
Granted: 1995-06-29
Abstract: An adjustable desk-top assembly is disclosed having upper, lower, and inner side panels, the upper and lower panels being spaced apart for forming a compartmentalized enclosure. The desk-top has an adjustable work surface capable of assuming a slope and a centralized cut-out portion therein for extending in a semi-circle around the user of the desk. The inner or door panels, are releasably secured and can be removed for accommodating any of a number of suitable components. The slope imparted to the work surface can be adjusted to an optimum level for the particular task and, by imparting greater slope and covering the components therein, a security measure is also provided.
Patent DE-3874379-T2 (DE)
Inventor: AQUILINA ANTHONY G
IPC: E05F15/08
Filed: 1988-02-18
Granted: 1993-03-18
Abstract: A door operator system includes a fluid cylinder (10) that has a cylinder body (12) and a rodless piston (30) adapted for reciprocation in the cylinder body (12). A carriage (50) which is adapted for reciprocation externally along the length of the cylinder body (12) is secured to the piston (30). An arm member (70) connects the cylinder carriage (50) to an associated sliding door. A control circuit is provided for controlling the operation of the fluid cylinder (10) and hence the position of the associated sliding door.
Patent DE-3875079-T2 (DE)
Inventor: BAKKA RAYMOND
IPC: H04L12/58
Filed: 1988-11-21
Granted: 1993-02-18
Abstract: It comprises input means (gme, gpe) configured to receive cells present on the input bus (BE) of the switching apparatus and output means (grs, grv) configured to supply cells on the output bus (BS) of the switching apparatus. 
<??>The input means comprise a call circuit (gpe) detecting a call signal (adl) coming from the switching apparatus and commanding the writing of the cell present on the input bus (BE), to an input memory (gme). The output means comprise a send circuit (gpl) receiving an availability signal (fv) and determining the sending of the cell contained by an output register (grs, grv) on the output bus (BS). 
<IMAGE>
Patent DE-3879012-T2 (DE)
Inventor: KOKOSHVILI SIMON M
IPC: G02B26/02
Filed: 1988-05-23
Granted: 1994-01-20
Abstract: A bypass switch wherein a spherical reflector is movable between first and second positions relative to an array of optical transceivers, at locations, designated the "S" (source), "D" (detector), "I" (input fiber), "O" (output fiber), and "L1" and "L2" (first and second loop) locations. An optical fiber ("loop fiber") has its ends registered at the L1 and L2 locations. The six optical transceiver terminal locations are characterized by first and second symmetry points. The first symmetry point is midway between the S and O locations and midway between the I and D locations. The second symmetry point is midway the I and O locations, midway between the S and L2 locations, and midway between the L1 and D locations. In the first reflector position, the center of curvature is coincident with the first symmetry point. In the second reflector position, the center of curvature is coincident with the second symmetry point. A simple geometric configuration has the six transceiver locations equidistantly spaced along a line (S, D, I, O, L1, L2), with the first symmetry point between the D and I locations and the second between the I and O locations.
Patent DE-3882956-T2 (DE)
Inventor: TATSUOKA TOSHIO
IPC: C07D513/00
Filed: 1988-12-22
Granted: 1994-01-05
Abstract: Compounds having the formula (I): <CHEM> wherein A is -CH2-, -O-, or -S-; R<1> is CH3 or OCH3; R<2> is hydroxy or carboxy which may be optionally esterified or amidated; R<3> is H or a lower alkyl; and n is 0 or an integer of 1 to 6, and pharmaceutically acceptable salts thereof, are disclosed. The compounds, and pharmaceutical compositions containing them, are used in therapy for cerebral insufficiency.
Patent TR-199902535-T2 (TR)
Inventor: SPADONI LUCA
IPC: C11D3/00
Filed: 1998-04-14
Abstract: Bu bulus bir asit, karbonat kaynagi ve istege bagli olarak bir baglayicidan olusan kuru efervesan granüllere iliskindir, adi geçen asit, karbonat kaynagi ve istege bagli baglayici yakin fiziksel temas içindedir. Bulus ayrica bir asit ve bir karbonat kaynagindan olusan efervesans malzemesini içeren, efervesans indisi (EI) en az 50 olan granül bilesimler sunmaktadir. Granül bilesimler, adi geçen önceden olusturulmus kuru efervesan granüller granül bilesimlere, özellikle deterjan bilesimlerine ilave edilerek elde edilebilir. Bu granül deterjan bilesimleri bir yikama/ bastirma çözeltisi elde etmek üzere suyla seyreltildiginde daha iyi efervesans elde edilir, dolayisiyla daha iyi erime/dagilma özelliklerine ve kirli çamasirlar üzerinde daha iyi leke çikarma performansina sahiptir.
Patent DE-60003280-T2 (DE)
Inventor: THAYER JONATHAN
IPC: B65D81/32
Filed: 2000-09-18
Granted: 2004-04-29
Abstract: A multi-piston, ratcheted dispensing device for cosmetic and pharmaceutical formulations comprising a hollow body, the body being interiorly divided into at least two channels; a ratchet cup for applying force to at least two ratcheting members, each ratcheting member being in rigid contact with one of at least two pistons, each piston being disposed within the channels; at least one recoil member for biasing the ratchet cup away from the pistons; exit orifices disposed within the body; and, optionally, conductors for directing the dispensed product, sealing mechanisms to prevent dry-out of the product and an actuator.
Patent DE-60007565-T2 (DE)
Inventor: TOSI SERGIO
IPC: B41C1/00
Filed: 2000-01-26
Granted: 2004-12-16
Abstract: The process for realising matrices, in particular for decorating ceramic tiles, comprises: preparation of a usual silk screen (1) engraved with a predetermined design; a closing-off, on one side of the screen (1), of holes (4) in engraved zones of the screen (1) over a portion of a depth of the screen (1), creating cavities (2) which all together give rise to a recessed engraved design; the zones of the screen (1) affording the cavities (2) being brought into contact with a surface (11) in order to transfer thereon amounts of a substance contained in the cavities (2). <IMAGE>
Patent DE-60008011-T2 (DE)
Inventor: FINAROV ALEXANDER
IPC: G01N21/01
Filed: 2000-10-06
Granted: 2004-10-21
Abstract: An optical measurement device is presented. The device is attachable to the patient's body and adapted for performing non-invasive measurements of blood-related signals. The device comprises a measurement unit for applying optical measurements to a first region on the patient's extreme organ, and an occlusion assembly for applying over-systolic pressure to a second region on the patient's body located upstream of the first location with respect to a normal blood flow direction. A substantially flexible, heating element is provided within the measurement unit, and is accommodated so as to engage at least a part of the first region for heating it to a desired temperature.
Patent DE-60010634-T2 (DE)
Inventor: MAYS RALPH C
IPC: A61B17/16
Filed: 2000-12-21
Granted: 2005-06-16
Abstract: A highly flexible instrument particularly useful in medical and dental applications is elongated and formed of a plurality of flexible metallic strands, at least one strand being spirally wound and having a scraping edge thereon. <IMAGE>
Patent DE-60016406-T2 (DE)
Inventor: LANGE M
IPC: C08F8/30
Filed: 2000-06-06
Granted: 2005-12-01
Abstract: A composition prepared by reacting(A) an esterified carboxy-containing interpolymer, said interpolymer being derived from at least two monomers, (i) one of said monomers being at least one vinyl aromatic monomer and (ii) the other of said monomers being at least one alpha, beta-unsaturated acylating agent, and having, before esterification, {overscore (M)}n determined by gel permeation chromatography ranging from about 8,000 to about 350,000, wherein from about 80% to about 99% of the carboxylic groups of said interpolymer are esterified, wherein from about 80 to about 100% of the ester groups contain from 8 to about 23 carbon atoms and from 0 to about 20% of the ester groups contain from 2 to 7 carbon atoms, with(B) a hydrocarbyl substituted carboxylic acid or functional derivative thereof wherein the hydrocarbyl group comprises from about 10 to about 400 carbon atoms, and (C) an amine having an average of more than 1 condensable N-H group, in any order or simultaneously, or with the preformed reaction product of (B) and (C) wherein said preformed reaction product has at least one condensable N-H group. Depending upon the relative amounts of reactant (A) and (B) used, a composition which acts primarily as a viscosity improver with dispersant properties (DVM) or primarily as a dispersant with viscosity improving properties (VMD) may be prepared or compositions with properties intermediate between these.
Patent DE-60022909-T2 (DE)
Inventor: MCDANIEL MAX P
IPC: B01J21/06
Filed: 2000-12-01
Granted: 2006-06-22
Abstract: This invention provides catalyst compositions that are useful for polymerizing at least one monomer to produce a polymer. This invention also provides catalyst compositions that are useful for polymerizing at least one monomer to produce a polymer, wherein said catalyst composition comprises a post-contacted organometal compound, a post-contacted organoaluminum compound, and a post-contacted treated solid oxide compound.
Patent DE-60032001-T2 (DE)
Inventor: OKUDA MASAHIRO
IPC: C12N9/74
Filed: 2000-09-22
Granted: 2007-05-31
Abstract: The present invention is to provide a means for the stabilization of thrombin and a stabilized thrombin-containing composition having a good reproducibility of the measurement. There are provided a means for the stabilization of thrombin, characterized in that, effective amount (s) of one or more which is/are selected from calcium ion, surfactant and protein is/are contained and a stabilized thrombin-containing composition as well. There are also provided a means for the stabilization of thrombin where an effective amount of a water-soluble organic acid is jointly used in addition to the above and a stabilized thrombin-containing composition as well. There is further provided a thrombin-containing composition having an extremely high measurement reproducibility using thrombin and stabilizer for thrombin where one or more high-molecular polysaccharides or synthetic polymers is/are contained in the above-mentioned stabilized thrombin-containing composition.
Patent DE-60033672-T2 (DE)
Inventor: KAUFMAN JEFFREY R
IPC: G06F3/12
Filed: 2000-08-18
Granted: 2007-11-08
Abstract: A printer (10) which is configured to automatically transmit data, such as critical and non-critical printer data, and route that data through at least one of a plurality of communication channels and services, such as via e-mail or mobile wireless equipment (e.g. an Internet-ready pager (150), a Personal Communications Service (PCS) phone (160) or a wireless Personal Digital Assistant (PDA) (170)). Preferably, the printer is configured such that it can be programmed and controlled from a remote location. Preferably, the printer is configured such that new label formats can be added from a remote location, and label formats stored in the printer can be viewed and modified from a remote location. Preferably, the printer is also configured such that barcode rendering algorithms can be downloaded to the printer, and such that printer settings can be viewed and modified from a remote location, and thereafter can be downloaded to the printer and/or to other printers (10a, 10b, 10c) in a network to facilitate cloning.